In this review, we highlight the significant progress made in the last two decades regarding LOXL2 expression patterns in tumour samples, the mechanisms regulating its expression levels, targets influencing tumour progression, and the valuable insights gained from genetically modified mouse models. The gene discussed is LOXL2; the disease is neoplasm.